| scholarly article | Q13442814 |
| P2093 | author name string | A. D. O'Brien | |
| H. W. Moon | |||
| J. E. Samuel | |||
| S. C. Whipp | |||
| V. M. Gordon | |||
| P2860 | cites work | Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications | Q24561689 |
| Evidence that glutamic acid 167 is an active-site residue of Shiga-like toxin I | Q24651553 | ||
| Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 | Q25938983 | ||
| Colonic biopsy in verotoxin-induced hemorrhagic colitis and thrombotic thrombocytopenic purpura (TTP). | Q33453213 | ||
| The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli | Q33457864 | ||
| Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins. | Q34049372 | ||
| Experimental edema disease of swine (E. coli enterotoxemia). 3. Pathology and pathogenesis | Q34238797 | ||
| Mutational analysis of the Shiga toxin and Shiga-like toxin II enzymatic subunits | Q36165342 | ||
| Infection by verocytotoxin-producing Escherichia coli | Q36634680 | ||
| Serological responses to the B subunit of Shiga-like toxin 1 and its peptide fragments indicate that the B subunit is a vaccine candidate to counter action of the toxin | Q36973479 | ||
| Comparison of the glycolipid receptor specificities of Shiga-like toxin type II and Shiga-like toxin type II variants | Q36977977 | ||
| Shiga and Shiga-like toxins | Q37063416 | ||
| Purification and characterization of a Shigella dysenteriae 1-like toxin produced by Escherichia coli | Q37112219 | ||
| Quantitative microtiter cytotoxicity assay for Shigella toxin. | Q40230921 | ||
| Selection and characterization of ricin toxin A-chain mutations in Saccharomyces cerevisiae | Q40646196 | ||
| Role of arginine 180 and glutamic acid 177 of ricin toxin A chain in enzymatic inactivation of ribosomes | Q40647546 | ||
| Role of glutamic acid 177 of the ricin toxin A chain in enzymatic inactivation of ribosomes | Q40651036 | ||
| Mortality and morbidity from invasive bacterial infections during a clinical trial of acellular pertussis vaccines in Sweden. | Q41374569 | ||
| Epidemic Shiga Bacillus Dysentery in Central America. I. Etiologic Investigations in Guatemala, 1969 | Q47770578 | ||
| Reproduction of Edema Disease of Swine with Purified Shiga-like Toxin-II Variant | Q54703471 | ||
| Production of Shiga-Like Toxin by Escherichia coli | Q57563903 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | microbiology | Q7193 |
| immunology | Q101929 | ||
| P304 | page(s) | 485-490 | |
| P577 | publication date | 1992-02-01 | |
| P1433 | published in | Infection and Immunity | Q6029193 |
| P1476 | title | An enzymatic mutant of Shiga-like toxin II variant is a vaccine candidate for edema disease of swine | |
| P478 | volume | 60 |
| Q37190873 | A DNA vaccine encoding the enterohemorragic Escherichia coli Shiga-like toxin 2 A2 and B subunits confers protective immunity to Shiga toxin challenge in the murine model |
| Q27026551 | Advances in the development of enterohemorrhagic Escherichia coli vaccines using murine models of infection |
| Q38519709 | Binding of shiga toxin 2e to porcine erythrocytes in vivo and in vitro |
| Q35216120 | Bovine immune response to shiga-toxigenic Escherichia coli O157:H7 |
| Q35548775 | Coexpression of the B subunit of Shiga toxin 1 and EaeA from enterohemorrhagic Escherichia coli in Vibrio cholerae vaccine strains |
| Q33605233 | Comparison of the relative toxicities of Shiga-like toxins type I and type II for mice |
| Q33348633 | Development of DNA vaccines against hemolytic-uremic syndrome in a murine model |
| Q37427473 | Effectiveness of F18+ Fimbrial Antigens Released by a Novel Autolyzed Salmonella Expression System as a Vaccine Candidate against Lethal F18+ STEC Infection |
| Q50977488 | Effectiveness of egg yolk antibody against shiga toxin II variant toxicity in vitro and in vivo. |
| Q39454929 | Evaluation of biological safety in vitro and immunogenicity in vivo of recombinant Escherichia coli Shiga toxoids as candidate vaccines in cattle |
| Q37618214 | Evaluation of recombinant forms of the shiga toxin variant Stx2eB subunit and non-toxic mutant Stx2e as vaccine candidates against porcine edema disease. |
| Q38313654 | Histomorphometric characteristics of immune cells in small intestine of pigs perorally immunized with vaccine candidate F18ac nonenterotoxigenic E. coli strain |
| Q33965188 | Neutralizing antibodies to Shiga toxin type 2 (Stx2) reduce colonization of mice by Stx2-expressing Escherichia coli O157:H7. |
| Q24550740 | Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infections |
| Q33988094 | Persistent colonization of sheep by Escherichia coli O157:H7 and other E. coli pathotypes |
| Q33923243 | Prevention of edema disease in pigs by vaccination with verotoxin 2e toxoid. |
| Q35012362 | Protection against Shiga toxin 1 challenge by immunization of mice with purified mutant Shiga toxin 1. |
| Q35665444 | Protection of piglets against Edema disease by maternal immunization with Stx2e toxoid |
| Q39824053 | Protective immunity to Shiga-like toxin I following oral immunization with Shiga-like toxin I B-subunit-producing Vibrio cholerae CVD 103-HgR. |
| Q33883465 | Protective immunization of mice with an active-site mutant of subtilase cytotoxin of Shiga toxin-producing Escherichia coli |
| Q34033376 | Recombinant Shiga toxin B-subunit-keyhole limpet hemocyanin conjugate vaccine protects mice from Shigatoxemia |
| Q33599604 | Shiga toxin-induced tumor necrosis factor alpha expression: requirement for toxin enzymatic activity and monocyte protein kinase C and protein tyrosine kinases |
| Q35068024 | Simple method for Shiga toxin 2e purification by affinity chromatography via binding to the divinyl sulfone group |
| Q92153341 | Structural and Functional Characterization of Stx2k, a New Subtype of Shiga Toxin 2 |
| Q35461166 | Vaccination with genetically modified Shiga-like toxin IIe prevents edema disease in swine |
Search more.